Skip to Main content Skip to Navigation
Journal articles

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program

Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02076926
Contributor : Xavier Chard-Hutchinson <>
Submitted on : Friday, March 22, 2019 - 2:32:46 PM
Last modification on : Wednesday, August 19, 2020 - 11:58:42 AM

Links full text

Identifiers

Citation

Roch Houot, Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, Jean Marc Schiano de Collela, et al.. Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program. Blood, American Society of Hematology, 2018, 132 (1), pp.1638. ⟨10.1182/blood-2018-99-110960⟩. ⟨hal-02076926⟩

Share

Metrics

Record views

100